KANAPH THERAPEUTICS

Kanaph Therapeutics is a biotech with activities that range from drug discovery to early-stage clinical trials. We are dedicated to developing next-generation therapeutics for oncology and autoimmune diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor microenvironment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.

#People #Financial #Website #More

KANAPH THERAPEUTICS

Industry:

Biotechnology Life Science Pharmaceutical

Founded:

2019-02-14

Address:

Yongsan, Seoul-t'ukpyolsi, South Korea

Country:

South Korea

Website Url:

http://www.kanaphtx.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

27 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Google Maps JsDelivr AJAX Libraries API Pound Sterling

Current Employees Featured

byoung-chul-lee_image

Byoung-Chul Lee
Byoung-Chul Lee Founder & Chief Executive Officer @ Kanaph Therapeutics
Founder & Chief Executive Officer

Founder

byoung-chul-lee_image

Byoung-Chul Lee

Investors List

time-folio-asset-management_image

Official Site Inspections

http://www.kanaphtx.com

Host Informations
Whois Informations

Loading ...